Katie Tiemeyer

Katie is an MD-PhD student from Athens, Georgia with a strong interest in the glycobiological mechanisms that drive disease. Katie completed her undergraduate education at Boston University where she earned degrees in Biochemistry and Molecular Biology (BA, with Honors) and Vocal Performance (BM). While at BU, Katie completed her undergraduate research thesis in the lab of Kim McCall, where she interrogated the glycosylation state of a glial phagocytosis receptor in Drosophila. She also contributed to characterization of the mechanisms by which defective glial phagocytosis begets age-dependent neurodegeneration in Drosophila.

After graduating in 2021, Katie accepted a position in the lab of Carolyn Bertozzi at Stanford University where she worked closely with a physician-scientist to develop the first total glycosylation profile of the human platelet protein GPIb alpha. At Yale, Katie hopes to leverage her background in glycobiology to explore the roles of glycans in human disease, with a special interest in understanding the pathogenic consequences of altered protein glycosylation in cancer and neurodegenerative disease.

Outside of science and medicine, Katie sings with the Yale Schola Cantorum and enjoys playing piano, knitting/crocheting, and fostering kittens.